-
1
-
-
0025099787
-
Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus
-
Call KM, Glaser T, Ito CY, Buckler AJ, Pelletier J, et al. (1990) Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell 60: 509-520.
-
(1990)
Cell
, vol.60
, pp. 509-520
-
-
Call, K.M.1
Glaser, T.2
Ito, C.Y.3
Buckler, A.J.4
Pelletier, J.5
-
2
-
-
0025291908
-
The candidate Wilms' tumour gene is involved in genitourinary development
-
Pritchard-Jones K, Fleming S, Davidson D, Bickmore W, Porteous D, et al. (1990) The candidate Wilms' tumour gene is involved in genitourinary development. Nature 346: 194-197.
-
(1990)
Nature
, vol.346
, pp. 194-197
-
-
Pritchard-Jones, K.1
Fleming, S.2
Davidson, D.3
Bickmore, W.4
Porteous, D.5
-
3
-
-
0025644455
-
Tissue, developmental, and tumor-specific expression of divergent transcripts in Wilms tumor
-
Huang A, Campbell CE, Bonetta L, McAndrews-Hill MS, Chilton-MacNeill S, et al. (1990) Tissue, developmental, and tumor-specific expression of divergent transcripts in Wilms tumor. Science 250: 991-994.
-
(1990)
Science
, vol.250
, pp. 991-994
-
-
Huang, A.1
Campbell, C.E.2
Bonetta, L.3
McAndrews-Hill, M.S.4
Chilton-MacNeill, S.5
-
4
-
-
0030812823
-
The Wilms' tumor gene is expressed in a subset of CD34+ progenitors and downregulated early in the course of differentiation in vitro
-
Maurer U, Brieger J, Weidmann E, Mitrou PS, Hoelzer D, et al. (1997) The Wilms' tumor gene is expressed in a subset of CD34+ progenitors and downregulated early in the course of differentiation in vitro. Exp Hematol 25: 945-950.
-
(1997)
Exp Hematol
, vol.25
, pp. 945-950
-
-
Maurer, U.1
Brieger, J.2
Weidmann, E.3
Mitrou, P.S.4
Hoelzer, D.5
-
5
-
-
0027328694
-
The Wilms tumour gene WT1 is expressed in murine mesoderm-derived tissues and mutated in a human mesothelioma
-
Park S, Schalling M, Bernard A, Maheswaran S, Shipley GC, et al. (1993) The Wilms tumour gene WT1 is expressed in murine mesoderm-derived tissues and mutated in a human mesothelioma. Nat Genet 4: 415-420.
-
(1993)
Nat Genet
, vol.4
, pp. 415-420
-
-
Park, S.1
Schalling, M.2
Bernard, A.3
Maheswaran, S.4
Shipley, G.C.5
-
6
-
-
0025947718
-
Expression of the Wilms' tumor gene WT1 in the murine urogenital system
-
Pelletier J, Schalling M, Buckler AJ, Rogers A, Haber DA, et al. (1991) Expression of the Wilms' tumor gene WT1 in the murine urogenital system. Genes Dev 5: 1345-1356.
-
(1991)
Genes Dev
, vol.5
, pp. 1345-1356
-
-
Pelletier, J.1
Schalling, M.2
Buckler, A.J.3
Rogers, A.4
Haber, D.A.5
-
7
-
-
0031048878
-
Aberrant overexpression of the Wilms tumor gene (WT1) in human leukemia
-
Inoue K, Ogawa H, Sonoda Y, Kimura T, Sakabe H, et al. (1997) Aberrant overexpression of the Wilms tumor gene (WT1) in human leukemia. Blood 89: 1405-1412.
-
(1997)
Blood
, vol.89
, pp. 1405-1412
-
-
Inoue, K.1
Ogawa, H.2
Sonoda, Y.3
Kimura, T.4
Sakabe, H.5
-
8
-
-
0028811234
-
The Wilms' tumor gene is frequently expressed in acute myeloblastic leukemias and may provide a marker for residual blast cells detectable by PCR
-
Brieger J, Weidmann E, Maurer U, Hoelzer D, Mitrou PS, et al. (1995) The Wilms' tumor gene is frequently expressed in acute myeloblastic leukemias and may provide a marker for residual blast cells detectable by PCR. Ann Oncol 6: 811-816.
-
(1995)
Ann Oncol
, vol.6
, pp. 811-816
-
-
Brieger, J.1
Weidmann, E.2
Maurer, U.3
Hoelzer, D.4
Mitrou, P.S.5
-
9
-
-
0038011942
-
Significant correlation between the degree of WT1 expression and the International Prognostic Scoring System Score in patients with myelodysplastic syndromes
-
Cilloni D, Gottardi E, Messa F, Fava M, Scaravaglio P, et al. (2003) Significant correlation between the degree of WT1 expression and the International Prognostic Scoring System Score in patients with myelodysplastic syndromes. J Clin Oncol 21: 1988-1995.
-
(2003)
J Clin Oncol
, vol.21
, pp. 1988-1995
-
-
Cilloni, D.1
Gottardi, E.2
Messa, F.3
Fava, M.4
Scaravaglio, P.5
-
10
-
-
0032992295
-
Expression of the Wilms' tumor gene WT1 in solid tumors and its involvement in tumor cell growth
-
Oji Y, Ogawa H, Tamaki H, Oka Y, Tsuboi A, et al. (1999) Expression of the Wilms' tumor gene WT1 in solid tumors and its involvement in tumor cell growth. Jpn J Cancer Res 90: 194-204.
-
(1999)
Jpn J Cancer Res
, vol.90
, pp. 194-204
-
-
Oji, Y.1
Ogawa, H.2
Tamaki, H.3
Oka, Y.4
Tsuboi, A.5
-
11
-
-
0033966369
-
HLA class I-restricted lysis of leukemia cells by a CD8(+) cytotoxic T-lymphocyte clone specific for WT1 peptide
-
Ohminami H, Yasukawa M, Fujita S (2000) HLA class I-restricted lysis of leukemia cells by a CD8(+) cytotoxic T-lymphocyte clone specific for WT1 peptide. Blood 95: 286-293.
-
(2000)
Blood
, vol.95
, pp. 286-293
-
-
Ohminami, H.1
Yasukawa, M.2
Fujita, S.3
-
12
-
-
0034112824
-
Human cytotoxic T-lymphocyte responses specific for peptides of the wild-type Wilms' tumor gene (WT1) product
-
Oka Y, Elisseeva OA, Tsuboi A, Ogawa H, Tamaki H, et al. (2000) Human cytotoxic T-lymphocyte responses specific for peptides of the wild-type Wilms' tumor gene (WT1) product. Immunogenetics 51: 99-107.
-
(2000)
Immunogenetics
, vol.51
, pp. 99-107
-
-
Oka, Y.1
Elisseeva, O.A.2
Tsuboi, A.3
Ogawa, H.4
Tamaki, H.5
-
13
-
-
0034176750
-
Selective elimination of leukemic CD34(+) progenitor cells by cytotoxic T lymphocytes specific for WT1
-
Gao L, Bellantuono I, Elsasser A, Marley SB, Gordon MY, et al. (2000) Selective elimination of leukemic CD34(+) progenitor cells by cytotoxic T lymphocytes specific for WT1. Blood 95: 2198-2203.
-
(2000)
Blood
, vol.95
, pp. 2198-2203
-
-
Gao, L.1
Bellantuono, I.2
Elsasser, A.3
Marley, S.B.4
Gordon, M.Y.5
-
14
-
-
0036451819
-
Enhanced induction of human WT1-specific cytotoxic T lymphocytes with a 9-mer WT1 peptide modified at HLA-A*2402-binding residues
-
Tsuboi A, Oka Y, Udaka K, Murakami M, Masuda T, et al. (2002) Enhanced induction of human WT1-specific cytotoxic T lymphocytes with a 9-mer WT1 peptide modified at HLA-A*2402-binding residues. Cancer Immunol Immunother 51: 614-620.
-
(2002)
Cancer Immunol Immunother
, vol.51
, pp. 614-620
-
-
Tsuboi, A.1
Oka, Y.2
Udaka, K.3
Murakami, M.4
Masuda, T.5
-
15
-
-
0037111734
-
Two distinct HLA-A0201-presented epitopes of the Wilms tumor antigen 1 can function as targets for leukemia-reactive CTL
-
Bellantuono I, Gao L, Parry S, Marley S, Dazzi F, et al. (2002) Two distinct HLA-A0201-presented epitopes of the Wilms tumor antigen 1 can function as targets for leukemia-reactive CTL. Blood 100: 3835-3837.
-
(2002)
Blood
, vol.100
, pp. 3835-3837
-
-
Bellantuono, I.1
Gao, L.2
Parry, S.3
Marley, S.4
Dazzi, F.5
-
16
-
-
8444248183
-
In vitro stimulation with WT1 peptide-loaded Epstein-Barr virus-positive B cells elicits high frequencies of WT1 peptide-specific T cells with in vitro and in vivo tumoricidal activity
-
Doubrovina ES, Doubrovin MM, Lee S, Shieh JH, Heller G, et al. (2004) In vitro stimulation with WT1 peptide-loaded Epstein-Barr virus-positive B cells elicits high frequencies of WT1 peptide-specific T cells with in vitro and in vivo tumoricidal activity. Clin Cancer Res 10: 7207-7219.
-
(2004)
Clin Cancer Res
, vol.10
, pp. 7207-7219
-
-
Doubrovina, E.S.1
Doubrovin, M.M.2
Lee, S.3
Shieh, J.H.4
Heller, G.5
-
17
-
-
12144291167
-
WT1 peptide-based immunotherapy for patients with lung cancer: Report of two cases
-
Tsuboi A, Oka Y, Osaki T, Kumagai T, Tachibana I, et al. (2004) WT1 peptide-based immunotherapy for patients with lung cancer: report of two cases. Microbiol Immunol 48: 175-184.
-
(2004)
Microbiol Immunol
, vol.48
, pp. 175-184
-
-
Tsuboi, A.1
Oka, Y.2
Osaki, T.3
Kumagai, T.4
Tachibana, I.5
-
18
-
-
33745686444
-
A phase I/ II trial of a WT1 (Wilms' tumor gene) peptide vaccine in patients with solid malignancy: Safety assessment based on the phase I data
-
Morita S, Oka Y, Tsuboi A, Kawakami M, Maruno M, et al. (2006) A phase I/ II trial of a WT1 (Wilms' tumor gene) peptide vaccine in patients with solid malignancy: safety assessment based on the phase I data. Jpn J Clin Oncol 36: 231-236.
-
(2006)
Jpn J Clin Oncol
, vol.36
, pp. 231-236
-
-
Morita, S.1
Oka, Y.2
Tsuboi, A.3
Kawakami, M.4
Maruno, M.5
-
19
-
-
4644289323
-
Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression
-
Oka Y, Tsuboi A, Taguchi T, Osaki T, Kyo T, et al. (2004) Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression. Proc Natl Acad Sci U S A 101: 13885-13890.
-
(2004)
Proc Natl Acad Sci U S A
, vol.101
, pp. 13885-13890
-
-
Oka, Y.1
Tsuboi, A.2
Taguchi, T.3
Osaki, T.4
Kyo, T.5
-
20
-
-
0742324477
-
Complete remission in a patient with recurrent acute myeloid leukemia induced by vaccination with WT1 peptide in the absence of hematological or renal toxicity
-
Mailander V, Scheibenbogen C, Thiel E, Letsch A, Blau IW, et al. (2004) Complete remission in a patient with recurrent acute myeloid leukemia induced by vaccination with WT1 peptide in the absence of hematological or renal toxicity. Leukemia 18: 165-166.
-
(2004)
Leukemia
, vol.18
, pp. 165-166
-
-
Mailander, V.1
Scheibenbogen, C.2
Thiel, E.3
Letsch, A.4
Blau, I.W.5
-
21
-
-
33750291285
-
Improved human T-cell responses against synthetic HLA-0201 analog peptides derived from the WT1 oncoprotein
-
Pinilla-Ibarz J, May RJ, Korontsvit T, Gomez M, Kappel B, et al. (2006) Improved human T-cell responses against synthetic HLA-0201 analog peptides derived from the WT1 oncoprotein. Leukemia 20: 2025-2033.
-
(2006)
Leukemia
, vol.20
, pp. 2025-2033
-
-
Pinilla-Ibarz, J.1
May, R.J.2
Korontsvit, T.3
Gomez, M.4
Kappel, B.5
-
22
-
-
33747085478
-
Peptide binding motif predictive algorithms correspond with experimental binding of leukemia vaccine candidate peptides to HLA-A*0201 molecules
-
Gomez-Nunez M, Pinilla-Ibarz J, Dao T, May RJ, Pao M, et al. (2006) Peptide binding motif predictive algorithms correspond with experimental binding of leukemia vaccine candidate peptides to HLA-A*0201 molecules. Leuk Res 30: 1293-1298.
-
(2006)
Leuk Res
, vol.30
, pp. 1293-1298
-
-
Gomez-Nunez, M.1
Pinilla-Ibarz, J.2
Dao, T.3
May, R.J.4
Pao, M.5
-
23
-
-
0030934741
-
The use of computer-assisted video image analysis for the quantification of CD8+ T lymphocytes producing tumor necrosis factor alpha spots in response to peptide antigens
-
Herr W, Linn B, Leister N, Wandel E, Meyer zum Buschenfelde KH, et al. (1997) The use of computer-assisted video image analysis for the quantification of CD8+ T lymphocytes producing tumor necrosis factor alpha spots in response to peptide antigens. J Immunol Methods 203: 141-152.
-
(1997)
J Immunol Methods
, vol.203
, pp. 141-152
-
-
Herr, W.1
Linn, B.2
Leister, N.3
Wandel, E.4
Meyer zum Buschenfelde, K.H.5
-
24
-
-
34147119079
-
Synthetic anticancer vaccine candidates: Rational design of antigenic peptide mimetics that activate tumor-specific T-cells
-
Douat-Casassus C, Marchand-Geneste N, Diez E, Gervois N, Jotereau F, et al. (2007) Synthetic anticancer vaccine candidates: rational design of antigenic peptide mimetics that activate tumor-specific T-cells. J Med Chem 50: 1598-1609.
-
(2007)
J Med Chem
, vol.50
, pp. 1598-1609
-
-
Douat-Casassus, C.1
Marchand-Geneste, N.2
Diez, E.3
Gervois, N.4
Jotereau, F.5
-
25
-
-
0037039298
-
Incorporation of azides into recombinant proteins for chemoselective modification by the Staudinger ligation
-
Kiick KL, Saxon E, Tirrell DA, Bertozzi CR (2002) Incorporation of azides into recombinant proteins for chemoselective modification by the Staudinger ligation. Proc Natl Acad Sci U S A 99: 19-24.
-
(2002)
Proc Natl Acad Sci U S A
, vol.99
, pp. 19-24
-
-
Kiick, K.L.1
Saxon, E.2
Tirrell, D.A.3
Bertozzi, C.R.4
-
26
-
-
0030959062
-
Comparison of the photochemical behavior of four different photoactivatable probes
-
Weber PJ, Beck-Sickinger AG (1997) Comparison of the photochemical behavior of four different photoactivatable probes. J Pept Res 49: 375-383.
-
(1997)
J Pept Res
, vol.49
, pp. 375-383
-
-
Weber, P.J.1
Beck-Sickinger, A.G.2
-
27
-
-
0024968835
-
A general method for site-specific incorporation of unnatural amino acids into proteins
-
Noren CJ, Anthony-Cahill SJ, Griffith MC, Schultz PG (1989) A general method for site-specific incorporation of unnatural amino acids into proteins. Science 244: 182-188.
-
(1989)
Science
, vol.244
, pp. 182-188
-
-
Noren, C.J.1
Anthony-Cahill, S.J.2
Griffith, M.C.3
Schultz, P.G.4
-
28
-
-
0000652848
-
Biosynthetic site-specific incorporation of a non-natural amino acid into a polypeptide
-
Bain JDGJ, Dix TA, Chamberlain AR, Diala ES (1989) Biosynthetic site-specific incorporation of a non-natural amino acid into a polypeptide. J Am Chem Soc 111: 8013-8014.
-
(1989)
J Am Chem Soc
, vol.111
, pp. 8013-8014
-
-
Bain, J.D.G.J.1
Dix, T.A.2
Chamberlain, A.R.3
Diala, E.S.4
-
29
-
-
0035811456
-
Peptide analogues of a subdominant epitope expressed in ebv-associated tumors: Synthesis and immunological activity
-
Marastoni M, Bazzaro M, Micheletti F, Gavioli R, Tomatis R (2001) Peptide analogues of a subdominant epitope expressed in ebv-associated tumors: synthesis and immunological activity. J Med Chem 44: 2370-2373.
-
(2001)
J Med Chem
, vol.44
, pp. 2370-2373
-
-
Marastoni, M.1
Bazzaro, M.2
Micheletti, F.3
Gavioli, R.4
Tomatis, R.5
-
30
-
-
0036311355
-
Cytotoxic T lymphocyte epitope analogues containing cis- or trans-4-aminocyclohexanecarboxylic acid residues
-
Marastoni M, Bazzaro M, Micheletti F, Gavioli R, Tomatis R (2002) Cytotoxic T lymphocyte epitope analogues containing cis- or trans-4-aminocyclohexanecarboxylic acid residues. Bioorg Med Chem 10: 3061-3066.
-
(2002)
Bioorg Med Chem
, vol.10
, pp. 3061-3066
-
-
Marastoni, M.1
Bazzaro, M.2
Micheletti, F.3
Gavioli, R.4
Tomatis, R.5
-
31
-
-
0033168016
-
Nonapeptide analogues containing (R)-3-hydroxybutanoate and beta-homoalanine oligomers: Synthesis and binding affinity to a class I major histocompatibility complex protein
-
Poenaru S, Lamas JR, Folkers G, Lopez de Castro JA, Seebach D, et al. (1999) Nonapeptide analogues containing (R)-3-hydroxybutanoate and beta-homoalanine oligomers: synthesis and binding affinity to a class I major histocompatibility complex protein. J Med Chem 42: 2318-2331.
-
(1999)
J Med Chem
, vol.42
, pp. 2318-2331
-
-
Poenaru, S.1
Lamas, J.R.2
Folkers, G.3
Lopez de Castro, J.A.4
Seebach, D.5
-
32
-
-
0032150303
-
Binding of rationally designed non-natural peptides to the human leukocyte antigen HLA-B*2705
-
Krebs S, Folkers G, Rognan D (1998) Binding of rationally designed non-natural peptides to the human leukocyte antigen HLA-B*2705. J Pept Sci 4: 378-388.
-
(1998)
J Pept Sci
, vol.4
, pp. 378-388
-
-
Krebs, S.1
Folkers, G.2
Rognan, D.3
-
33
-
-
33749578886
-
Synthesis and biological evaluation of two chemically modified peptide epitopes for the class I MHC protein HLAB705
-
Jones MA, Hislop AD, Snaith JS (2006) Synthesis and biological evaluation of two chemically modified peptide epitopes for the class I MHC protein HLAB705. Org Biomol Chem 4: 3769-3777.
-
(2006)
Org Biomol Chem
, vol.4
, pp. 3769-3777
-
-
Jones, M.A.1
Hislop, A.D.2
Snaith, J.S.3
-
34
-
-
2542461354
-
Functional and structural characteristics of NY-ESO-1-related HLA A2-restricted epitopes and the design of a novel immunogenic analogue
-
Webb AI, Dunstone MA, Chen W, Aguilar MI, Chen Q, et al. (2004) Functional and structural characteristics of NY-ESO-1-related HLA A2-restricted epitopes and the design of a novel immunogenic analogue. J Biol Chem 279: 23438-23446.
-
(2004)
J Biol Chem
, vol.279
, pp. 23438-23446
-
-
Webb, A.I.1
Dunstone, M.A.2
Chen, W.3
Aguilar, M.I.4
Chen, Q.5
-
35
-
-
24744470278
-
T cell determinants incorporating beta-amino acid residues are protease resistant and remain immunogenic in vivo
-
Webb AI, Dunstone MA, Williamson NA, Price JD, de Kauwe A, et al. (2005) T cell determinants incorporating beta-amino acid residues are protease resistant and remain immunogenic in vivo. J Immunol 175: 3810-3818.
-
(2005)
J Immunol
, vol.175
, pp. 3810-3818
-
-
Webb, A.I.1
Dunstone, M.A.2
Williamson, N.A.3
Price, J.D.4
de Kauwe, A.5
-
36
-
-
0034609821
-
Melanoma peptide MART-1(27-35) analogues with enhanced binding capacity to the human class I histocompatibility molecule HLA-A2 by introduction of a beta-amino acid residue: Implications for recognition by tumor-infiltrating lymphocytes
-
Guichard G, Zerbib A, Le Gal FA, Hoebeke J, Connan F, et al. (2000) Melanoma peptide MART-1(27-35) analogues with enhanced binding capacity to the human class I histocompatibility molecule HLA-A2 by introduction of a beta-amino acid residue: implications for recognition by tumor-infiltrating lymphocytes. J Med Chem 43: 3803-3808.
-
(2000)
J Med Chem
, vol.43
, pp. 3803-3808
-
-
Guichard, G.1
Zerbib, A.2
Le Gal, F.A.3
Hoebeke, J.4
Connan, F.5
-
37
-
-
0030007650
-
Partially modified retro-inverso pseudopeptides as non-natural ligands for the human class I histocompatibility molecule HLA-A2
-
Guichard G, Connan F, Graff R, Ostankovitch M, Muller S, et al. (1996) Partially modified retro-inverso pseudopeptides as non-natural ligands for the human class I histocompatibility molecule HLA-A2. J Med Chem 39: 2030-2039.
-
(1996)
J Med Chem
, vol.39
, pp. 2030-2039
-
-
Guichard, G.1
Connan, F.2
Graff, R.3
Ostankovitch, M.4
Muller, S.5
-
38
-
-
0035060232
-
Synthesis and antigenic properties of reduced peptide bond analogues of an immunodominant epitope of the melanoma MART-1 protein
-
Quesnel A, Zerbib A, Connan F, Guillet JG, Briand JP, et al. (2001) Synthesis and antigenic properties of reduced peptide bond analogues of an immunodominant epitope of the melanoma MART-1 protein. J Pept Sci 7: 157-165.
-
(2001)
J Pept Sci
, vol.7
, pp. 157-165
-
-
Quesnel, A.1
Zerbib, A.2
Connan, F.3
Guillet, J.G.4
Briand, J.P.5
|